Patents Assigned to NEUBASE THERAPEUTICS, INC.
  • Modified peptide nucleic acid compositions
    Patent number: 11603530
    Abstract: The present disclosure relates to compounds useful for the detection or modulation of target nucleic acids, including DNA and RNA. The present disclosure further relates to methods for treatment of trinucleotide repeat disorders, which can include administration of oligonucleotide analogues that can bind pathogenic nucleotide repeats in DNA or RNA.
    Type: Grant
    Filed: April 15, 2021
    Date of Patent: March 14, 2023
    Assignee: NEUBASE THERAPEUTICS, INC.
    Inventors: Danith H. Ly, Shivaji A. Thadke, Ramesh U. Batwal, Dietrich A. Stephan